Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

Recruiting now

Conditions studied: Allergy and Immunology

In brief

The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.

Key facts

Study ID

NCT04751760

Run by

University Hospital, Toulouse

People needed

1376

Starts

2021-04-20

Expected to finish

2026-04-20

Last updated by the study team

2026-03-19

Who can join

Age: 1 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females 6 months' old or older
• Sensitization or allergy towards a trophallergen, an aeroallergen, hymenoptera venom or drug proven by:
• positive skin test (s)
• and / or IgE specific (s)> 0.1 kUA / L
• and / or anamnesis in favor of an allergic reaction of mediated IgE
• Social coverage up to date

You may not qualify if…

• Children younger than 6 months'old
• Children's weight less than 10 kg
• Pregnant or breastfeeding women
• Patients with cystic fibrosis
• Patients with dysimmune or autoimmune pathology
• Anamnesis in favor of a delayed allergy or a contact allergy.

Where it is running

• University Hospital — Toulouse, France (enrolling)
• Larrey hospital — Toulouse, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.